Adj. EPS $2.49, est. $2.07Rev. $18.09B, est. $17.31BKeytruda rev. $8.60B, est. $8.38BGardasil rev. $2.00B, est. $1.75BKeytruda Qlex rev. $830M, est. $699.6MWinrevair rev. $694M, est. $643.1MAnimal Health sales $1.68B, est. $1.69BSees FY sales $66.8B to $67.3B, saw $66.3B to $67.3BSees FY Adj. EPS $2.77 to $2.82, saw $2.66 to $2.76Still sees FY Adj. gross margin about 81%, est. 81%